Cardiovascular risk prediction in older adults with the use of biomarkers.
作者信息
Briasoulis Alexandros, Asleh Rabea
机构信息
Division of Cardiovascular Diseases, Section of Heart Failure and Transplant, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.
Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
出版信息
Ann Transl Med. 2018 Nov;6(Suppl 1):S50. doi: 10.21037/atm.2018.10.10.
Abstract
摘要
相似文献
1
Cardiovascular risk prediction in older adults with the use of biomarkers.使用生物标志物对老年人进行心血管风险预测。
Ann Transl Med. 2018 Nov;6(Suppl 1):S50. doi: 10.21037/atm.2018.10.10.
2
Vascular risk assessment in older adults without a history of cardiovascular disease.无心血管疾病病史的老年人的血管风险评估
Exp Gerontol. 2016 Jun 15;79:37-45. doi: 10.1016/j.exger.2016.03.002. Epub 2016 Mar 10.
3
Biomarkers for Prediction of Cardiovascular Events in Community-Dwelling Adults Aged 40 or Older.40岁及以上社区居住成年人心血管事件预测生物标志物
Int Heart J. 2020 Jan 31;61(1):109-114. doi: 10.1536/ihj.19-240. Epub 2019 Dec 26.
4
Review on cardiovascular risk prediction.心血管风险预测综述
Cardiovasc Ther. 2015 Apr;33(2):62-70. doi: 10.1111/1755-5922.12110.
5
Prediction of myocardial infarction, stroke and cardiovascular mortality with urinary biomarkers of oxidative stress: Results from a large cohort study.尿氧化应激生物标志物对心肌梗死、卒中和心血管死亡率的预测：一项大型队列研究的结果。
Int J Cardiol. 2018 Dec 15;273:223-229. doi: 10.1016/j.ijcard.2018.08.002. Epub 2018 Aug 3.
6
Biomarkers of cardiovascular disease: contributions to risk prediction in individuals with diabetes.心血管疾病生物标志物：在糖尿病个体中的风险预测贡献。
Diabetologia. 2018 May;61(5):987-995. doi: 10.1007/s00125-017-4442-9. Epub 2017 Sep 28.
7
The sweet spot: fasting glucose, cardiovascular disease, and mortality in older adults with diabetes: a nationwide population-based study.最佳切点：糖尿病老年患者的空腹血糖、心血管疾病与死亡率：一项全国范围内基于人群的研究。
Cardiovasc Diabetol. 2020 Apr 1;19(1):44. doi: 10.1186/s12933-020-01021-8.
8
Cardiovascular biomarkers and their utility in the older adult.心血管生物标志物及其在老年人中的应用。
Curr Cardiovasc Risk Rep. 2012 Oct;6(5):397-403. doi: 10.1007/s12170-012-0262-0. Epub 2012 Jul 28.
9
Cardiovascular biomarkers predict fragility fractures in older adults.心血管生物标志物可预测老年人的脆性骨折。
Heart. 2019 Mar;105(6):449-454. doi: 10.1136/heartjnl-2018-313741. Epub 2018 Oct 15.
10
Developing and assessing cardiovascular biomarkers.开发和评估心血管生物标志物。
Transl Res. 2012 Apr;159(4):265-76. doi: 10.1016/j.trsl.2012.01.003. Epub 2012 Jan 27.
引用本文的文献
1
Clinical Presentation and Outcomes in Real-Life Management of Elderly Patients Aged ≥75 Years Presenting with Acute Myocardial Infarction.老年患者（年龄≥75 岁）急性心肌梗死的真实世界临床特征和结局。
Anatol J Cardiol. 2022 Apr;26(4):286-297. doi: 10.5152/AnatolJCardiol.2021.1096.
本文引用的文献
1
Clinical Implications of Revised Pooled Cohort Equations for Estimating Atherosclerotic Cardiovascular Disease Risk.修订后的汇总队列方程在估计动脉粥样硬化性心血管疾病风险中的临床意义。
Ann Intern Med. 2018 Jul 3;169(1):20-29. doi: 10.7326/M17-3011. Epub 2018 Jun 5.
2
Short-Term Global Cardiovascular Disease Risk Prediction in Older Adults.老年人短期全球心血管疾病风险预测。
J Am Coll Cardiol. 2018 Jun 5;71(22):2527-2536. doi: 10.1016/j.jacc.2018.02.050. Epub 2018 Mar 10.
3
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2017美国心脏病学会/美国心脏协会/美国医师协会/美国心脏病学学会/美国预防医学学院/美国老年病学会/美国药学协会/美国血液学会/美国预防医学学会/美国医学协会/美国初级保健医师学会成人高血压预防、检测、评估和管理指南：美国心脏病学会/美国心脏协会临床实践指南工作组报告
J Am Coll Cardiol. 2018 May 15;71(19):e127-e248. doi: 10.1016/j.jacc.2017.11.006. Epub 2017 Nov 13.
4
Biochemical risk markers and 10-year incidence of atherosclerotic cardiovascular disease: independent predictors, improvement in pooled cohort equation, and risk reclassification.生化风险标志物与动脉粥样硬化性心血管疾病的10年发病率：独立预测因素、合并队列方程的改进及风险重新分类
Am Heart J. 2017 Nov;193:95-103. doi: 10.1016/j.ahj.2017.08.002. Epub 2017 Aug 10.
5
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.《2017年心脏病和中风统计数据更新：美国心脏协会报告》
Circulation. 2017 Mar 7;135(10):e146-e603. doi: 10.1161/CIR.0000000000000485. Epub 2017 Jan 25.
6
Accuracy of the Atherosclerotic Cardiovascular Risk Equation in a Large Contemporary, Multiethnic Population.当代大型多民族人群中动脉粥样硬化性心血管疾病风险方程的准确性
J Am Coll Cardiol. 2016 May 10;67(18):2118-2130. doi: 10.1016/j.jacc.2016.02.055.
7
An analysis of calibration and discrimination among multiple cardiovascular risk scores in a modern multiethnic cohort.现代多民族队列中多种心血管风险评分的校准与鉴别分析。
Ann Intern Med. 2015 Feb 17;162(4):266-75. doi: 10.7326/M14-1281.
8
A systematic examination of the 2013 ACC/AHA pooled cohort risk assessment tool for atherosclerotic cardiovascular disease.对 2013 年 ACC/AHA pooled cohort 风险评估工具用于动脉粥样硬化性心血管疾病的系统检查。
J Am Coll Cardiol. 2014 Sep 9;64(10):959-68. doi: 10.1016/j.jacc.2014.06.1186.
9
Validation of the atherosclerotic cardiovascular disease Pooled Cohort risk equations.验证动脉粥样硬化性心血管疾病的汇总队列风险方程。
JAMA. 2014 Apr 9;311(14):1406-15. doi: 10.1001/jama.2014.2630.
10
Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort.比较 ACC/AHA 指南、成人治疗专家组 III 指南和欧洲心脏病学会指南在欧洲队列中用于心血管疾病预防的应用。
JAMA. 2014 Apr 9;311(14):1416-23. doi: 10.1001/jama.2014.2632.
Zotero 插件